F18 pet radiopharmaceuticals

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 is seeking a vendor to provide daily delivery of multiple F-18 PET radiopharmaceuticals to the Nuclear Medicine Service at Atlanta Veterans Affairs Medical Center in Decatur, Georgia. The required radiopharmaceuticals include F-18 FDG, NaF-F18, F18-beta-amyloid imaging agent, F18-Axumin, F18-Tauvid, F18-Cerianna, F18-Posluma, F18-Pylarify CAIX, choline PET radiopharmaceuticals, and F18-FET. The vendor must provide all necessary labor, supervision, and transportation for these deliveries. Prospective offerors must be registered in SAM.gov at the time of proposal submission to comply with federal requirements; failure to maintain active registration will result in the proposal being deemed non-responsive. This pre-solicitation notice was posted on February 19, 2026, with a due date for questions or initial responses by March 3, 2026. The actual solicitation will be launched on SAM.gov by the Department of Veterans Affairs once it becomes available.

This procurement is designated as a Total Small Business set-aside, restricting competition to qualified small business entities. The contract will have a base year performance period beginning March 20, 2026, with four optional one-year renewal periods available at the government's discretion, providing potential for extended engagement with the vendor. No specific award value, budget range, or incumbent contractor information is disclosed in this pre-solicitation notice. The radiopharmaceutical delivery requirement is classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and PSC code Q527 (Medical-Nuclear Medicine), indicating the specialized nature of this procurement. All responsible sources are encouraged to begin their SAM.gov registration process immediately to ensure compliance and readiness for the formal solicitation.